Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
Blood (2012) 120 (8): 1589–1596.
Currently there are no citedby results. Try again later.
